Leadership

Mike Fitzgibbons, CEO & Founder

Sector
Healthcare Technology

ClaritasRx is an enterprise SaaS platform providing data management, data analytics, and patient engagement tools to biopharma companies focused on specialty therapeutics.

2021

February


Questa Led $15M Series A Financing

ClaritasRx

"ClaritasRx is thrilled to have a partner like Questa with deep healthcare domain expertise and appreciation for our mission of using real world data to illuminate the patient journey."

Mike Fitzgibbons

Founder & CEO

Their story

Specialty and orphan drug manufacturers face significant challenges in tracking, managing, and supporting patient access. Historically, manufacturers relied on fragmented consulting analyses, often receiving delayed, infrequent, and incomplete data that limited their ability to optimize patient outcomes and market performance.

Recognizing this gap, Mike Fitzgibbons founded ClaritasRx in 2012 after years at Genentech, developing a deep understanding of the industry’s data challenges. His team created Ascend, a data management and analytics platform that streamlines specialty drug fulfillment, providing manufacturers with a real-time, comprehensive view of drug performance and patient adherence.

ClaritasRx remains committed to using data-driven insights to help patients maximize the benefits of specialty therapies and ensure continued access to life-changing treatments.

Our partnership

Our investment in ClaritasRx was the result of a multi-year research effort into how real-world data was being used in the complex specialty pharmacy market.  We developed the relationship with the company and its Founder, Mike Fitzgibbons, over several years before having the opportunity to invest.  

Since investing, we have been very active in recruiting senior leadership, strengthening and expanding the board of directors, and accelerating its investment in its commercialization and technology platforms to expand on its market leadership position.

"Specialty data aggregation and analytics is complex and underserved by legacy solutions. With a growing pipeline of therapies for cancer and rare diseases, Claritas Rx provides a unique technology solution at the center of brand and patient services teams. Having tracked their innovation for years, we are honored to be their first institutional investor and excited to build a market leader."

Brad Sloan, Managing Partner

Questa Capital